Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China · Delayed Price · Currency is CNY 30.28
-1.64 (-5.14%)
May 12, 2026, 3:04 PM CST
SHE:300878 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -218.13 | -229.73 | -147.43 | -8.95 | 48.81 | 96.5 |
Depreciation & Amortization | 62.88 | 62.88 | 67.52 | 46.65 | 42.38 | 26.99 |
Other Amortization | 1.1 | 1.1 | 2.14 | 2.36 | 2.62 | 3.06 |
Loss (Gain) From Sale of Assets | 0.99 | 0.99 | 0.47 | 0.01 | 0.63 | -0.07 |
Asset Writedown & Restructuring Costs | 108.76 | 108.76 | 84.03 | -3.9 | 0.4 | 0.11 |
Loss (Gain) From Sale of Investments | -1.12 | -1.12 | -91.12 | -12.6 | -14.79 | -0.26 |
Provision & Write-off of Bad Debts | - | - | 3.18 | -11.46 | 7.31 | 8.41 |
Other Operating Activities | -17.82 | 8.19 | 18.18 | 11.9 | 6.08 | 2.21 |
Change in Accounts Receivable | 165.64 | 165.64 | 72.92 | 63.42 | 38.67 | -151.67 |
Change in Inventory | 57.45 | 57.45 | -7.15 | -37.6 | -3.03 | -45.62 |
Change in Accounts Payable | -127.49 | -127.49 | -8.54 | 24.55 | 8.74 | 10.16 |
Operating Cash Flow | 52.68 | 67.09 | -27.17 | 58.29 | 145.18 | -67.74 |
Operating Cash Flow Growth | - | - | - | -59.85% | - | - |
Capital Expenditures | -54.31 | -67.17 | -126.92 | -139.29 | -173.39 | -171.1 |
Sale of Property, Plant & Equipment | 0.15 | 0.09 | 4.51 | 0.02 | 0.32 | 0.23 |
Cash Acquisitions | - | - | - | - | -9.79 | -32.27 |
Divestitures | - | 44.63 | 37.32 | - | - | 13.69 |
Investment in Securities | - | - | 241 | -240.57 | -5.16 | -2.91 |
Other Investing Activities | -10.74 | -20 | 6.76 | 240.01 | -254.41 | - |
Investing Cash Flow | -64.9 | -42.46 | 188.29 | 9.31 | -442.43 | -192.35 |
Long-Term Debt Issued | - | 65.3 | 189.01 | 377.04 | 288.81 | 50 |
Total Debt Issued | 138.3 | 65.3 | 189.01 | 377.04 | 288.81 | 50 |
Short-Term Debt Repaid | - | - | - | - | -0.5 | - |
Long-Term Debt Repaid | - | -187.82 | -326.71 | -275 | -64.02 | -28.65 |
Total Debt Repaid | -186.82 | -187.82 | -326.71 | -275 | -64.52 | -28.65 |
Net Debt Issued (Repaid) | -48.52 | -122.52 | -137.69 | 102.04 | 224.28 | 21.35 |
Repurchase of Common Stock | - | - | -50 | - | - | - |
Common Dividends Paid | -27.73 | -28.42 | -44.4 | -7.02 | -45.74 | -80.99 |
Other Financing Activities | -0.11 | -0.11 | -2 | 2.55 | 0.2 | 5.68 |
Financing Cash Flow | -76.36 | -151.06 | -234.09 | 97.57 | 178.74 | -53.96 |
Net Cash Flow | -88.58 | -126.42 | -72.97 | 165.17 | -118.51 | -314.06 |
Free Cash Flow | -1.62 | -0.08 | -154.1 | -81 | -28.21 | -238.84 |
Free Cash Flow Margin | -0.72% | -0.04% | -43.88% | -15.59% | -5.30% | -37.73% |
Free Cash Flow Per Share | -0.01 | -0.00 | -1.08 | -0.54 | -0.20 | -1.66 |
Cash Income Tax Paid | 15.91 | 5.55 | 30.67 | 34.29 | 27.98 | 69.23 |
Levered Free Cash Flow | 10.98 | 42.56 | -84.38 | 316 | -405.82 | -304.93 |
Unlevered Free Cash Flow | 10.98 | 42.56 | -78.54 | 321.9 | -402.44 | -303.58 |
Change in Working Capital | 116.02 | 116.02 | 35.85 | 34.29 | 51.73 | -204.69 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.